ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Vanda Pharmaceuticals, Inc. 

9620 Medical Center Drive
Suite 201
Rockville  Maryland  20850  U.S.A.
Phone: 301-294-9300 Fax: 301-294-1900


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Vanda Pharmaceuticals, Inc. (VNDA) Announces Availability of HETLIOZ™ (tasimelteon) For Non-24-Hour Sleep-Wake Disorder (Non-24) 4/10/2014 9:44:15 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA) Reports Fourth Quarter 2013 And Full Year 2013 Results 2/13/2014 11:14:10 AM    More...
FDA Approves Vanda Pharmaceuticals, Inc. (VNDA)'s Sleep Disorder Drug HETLIOZ™ 2/3/2014 6:44:54 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Fourth Quarter 2013 Financial Results On February 13, 2014 1/24/2014 6:45:58 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The 25th Annual Piper Jaffray Healthcare Conference 12/4/2013 6:21:37 AM    More...
Investors Can Sleep Soundly As FDA Panel Backs Vanda Pharmaceuticals, Inc. (VNDA)'s Drug For The Blind 11/15/2013 8:18:42 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA) Stock Trading Halted; FDA Advisory Committee to Review HETLIOZ™ NDA 11/14/2013 11:50:22 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA)'s Experimental Drug Helps The Blind Sleep, FDA Staff Says; Stock Soars +95.93% At Market Close (November 12, 2013) 11/12/2013 7:22:33 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA) Reports Third Quarter 2013 Results 11/7/2013 6:44:46 AM    More...
Vanda Pharmaceuticals, Inc. (VNDA) to Announce Third Quarter 2013 Financial Results on November 7, 2013 10/22/2013 6:11:47 AM    More...
12345678910...